Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Conceivex, Inc. Welcomes Adam Boris, Dr. David N. Madgy, and Jane Mary Sullivan as Newest Members of Company’s Board of Directors
  • USA - English


News provided by

Conceivex, Inc.

Dec 01, 2015, 06:00 ET

Share this article

Share toX

Share this article

Share toX

The Conception Kit® at-home system
The Conception Kit® at-home system

We are pleased to have this compliment of professionals as part of our team

Post this

Bloomfield Hills, MI (PRWEB) December 01, 2015 -- Conceivex, Inc. (http://www.conceptionkit.com), a privately owned reproductive healthcare company headquartered in Bloomfield Hills, MI, is pleased to announce the addition of Adam Boris, Dr. David N. Madgy, and Jane Mary Sullivan to its Board of Directors. Michael La Vean, Founder and President of Conceivex noted “The new directors bring a different level of healthcare industry expertise and guidance as the company continues to launch its core product and seeks to commercialize other corporate healthcare related technologies. We are pleased to have this compliment of professionals as part of our team.”

Adam Boris
Mr. Boris has more than 30 years’ experience in leadership positions with Fortune 500 and high-growth technology and service companies. As CEO of ICNet Systems, Inc., he grew the company to the leading product in clinical decision support in its category and successfully engineered the sale of ICNet to a Fortune 500 healthcare company. Mr. Boris also serves as a Board of Trustee for Norwegian American Hospital.

David N. Madgy, D.O.
Dr. Madgy currently serves as Chief of the Otolaryngology department at Detroit Medical Center, is among the attending staff at Providence Hospital and William Beaumont Hospital, and is a professor of Otolaryngology at Michigan State University.

Jane Mary Sullivan
Ms. Sullivan is a pioneer and entrepreneur having started and run two non-profits, a school for training home health aides, and two for-profit business in the home health industry. For over thirty years Sullivan has helped companies to adapt to new market conditions and has consulted with industry leaders.

The Conception Kit® at-home system, is a three month treatment that is used in the privacy of home. This medical device is an inexpensive alternative to invasive infertility procedures. It is the only cleared FDA treatment for low sperm count and sperm motility, or a hostile vaginal environment that is covered as a pharmacy benefit under a patient’s insurance policy. The Conception Kit® is eligible for reimbursement from some of the largest pharmacy benefit manager in the United State.

About the Conceivex, Inc. Conception Kit®

Conceivex, Inc. is a late stage medical device company dedicated to discovering and commercializing novel FDA approved technologies within the areas of Reproductive, Women’s, and Urological health. The highly complex medical challenge that Conceivex addresses is helping couples who struggle with a number of the root causes that lead to infertility to achieve a healthy conception naturally. The company’s lead product, the Conception Kit® at-home system, is the only FDA cleared treatment that is covered by insurance available to female and male patients who suffer from abnormalities such as a hostile vaginal environment, sperm motility issues, and low sperm count that can result in infertility. Achieving a “Best in Class” designation from Urologists and OB/GYN’s alike, the Conception Kit® at- home conception system is a fully integrated systematic treatment approach that reproductive specialists are defining as the “first step” in addressing a number of the root causes for infertility. Of significance, Conceivex, Inc. has secured NDC coding designation with approvals for insurance reimbursement through pharmacy benefit managers and medical payers.

Since the Conception Kit® became available more than 250 healthy babies have been conceived and born through the use of the Conception Kit®. During a Conceivex sponsored Consumer Research study of 500 targeted consumers, nearly 20% of the patient population conceived a child within 90 days.

A critical aspect to the Conception Kit® is that the device can be used as a stand-alone treatment, or in conjunction with other treatment modalities, or after other therapies have failed. For the first time, reproductive healthcare and treatment can be defined as a step by step treatment process that contains a number of care alternatives. Cost is no longer a deciding factor as well. The Conception Kit® at home system is reimbursed by Pharmacy Benefit Managers such as Express Scripts, Caremark, Pro Care RX and others through a drug code with no substitute. Patients can use the Conception Kit during the first twelve month prior to other medical benefits being reimbursed (making this a first step in step therapy).

Colleen Burell, Conceivex, Inc., http://www.conceptionkit.com/get-pregnant/pregnancy-success, +1 (312) 315-8788, [email protected]

Modal title

The Benefits of Conception Kit at-home system
View PDF
The Benefits of Conception Kit at-home system
The Benefits of Conception Kit at-home system

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.